Chemoinformaics analysis of 1,8-Dimethoxy-3-methylnaphthalene
| Molecular Weight | 202.253 | nRot | 2 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 19 |
| Exact Molecular Weight | 202.099 | nRing | 2 |
| Solubility: LogS | -2.021 | nHRing | 0 |
| Solubility: LogP | 1.521 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 11 |
| nHA | 2 | APOL | 32.6491 |
| nHD | 0 | BPOL | 17.5169 |
| QED | 0.607 |
| Synth | 5.955 |
| Natural Product Likeliness | 3.188 |
| NR-PPAR-gamma | 0.744 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.297 |
| Pgp-sub | 0 |
| HIA | 0.018 |
| CACO-2 | -4.738 |
| MDCK | 0.000017 |
| BBB | 0.704 |
| PPB | 0.61804 |
| VDSS | 1.572 |
| FU | 0.385377 |
| CYP1A2-inh | 0.02 |
| CYP1A2-sub | 0.131 |
| CYP2c19-inh | 0.029 |
| CYP2c19-sub | 0.872 |
| CYP2c9-inh | 0.054 |
| CYP2c9-sub | 0.082 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.206 |
| CYP3a4-inh | 0.466 |
| CYP3a4-sub | 0.581 |
| CL | 15.492 |
| T12 | 0.314 |
| hERG | 0.006 |
| Ames | 0.014 |
| ROA | 0.874 |
| SkinSen | 0.224 |
| Carcinogencity | 0.381 |
| EI | 0.025 |
| Respiratory | 0.341 |
| NR-Aromatase | 0.193 |
| Antiviral | No |
| Prediction | 0.655796 |